GSK is inviting academic scientists to enter their most innovative drug research proposals into its 2014 Discovery Fast Track Challenge – a programme designed to accelerate the translation of early-stage research into game-changing new medicines.
Building on the success of its first programme in 2013, which ran in the US and Canada, GSK is implementing the crowdsourcing challenge for a second year and expanding it to include Europe. Scientists whose entries are selected will collaborate with GSK’s Discovery Partnerships with Academia (DPAc) team, the sponsor of the challenge, to test their hypotheses on potential disease pathways or targets against GSK’s extensive library of compounds.